RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

DeepMind AI

Product
Developers: Google DeepMind (DeepMind Technologies)
Date of the premiere of the system: January, 2020
Branches: Pharmaceutics, medicine, health care

2019: Announcement

At the beginning of January, 2020 Google provided new AI technology which reveals a breast cancer at women with a bigger accuracy, than doctors-rengtenologi.

Google Health, Northwestern University, the British Center of researches of cancer, the Imperial center of Great Britain and Royal hospital of the District of Surrey participated in a research of new technology. The results published in the scientific magazine Nature showed that application of a new algorithm at diagnosis of a breast cancer allows to reduce the frequency of false positive and false-negative results.

Google provided new AI technology which reveals a breast cancer at women with a bigger accuracy, than doctors-rengtenologi

The AI algorithm was trained at mammograms of more than 15,000 women from the USA and by more than 76,000 women from Great Britain. The program allowed to reduce amount of false positive results by 5.7% at women from the USA and for 1.2% at women from Great Britain. Lozhnotritsatelny results met 9.4% less often in the USA and for 2.7% in Britain.

According to a research, a system exposed diagnoses more precisely, than specialists radiologists, even when doctors had an opportunity to study a mammogram repeatedly.

File:Aquote1.png
We hope that future applications on the basis of AI will be able to increase the accuracy and efficiency of the screening programs directed to early detection of a breast cancer and also will allow to reduce answering interval — the technical lead of Google Health Shravya Shetty and products manager Daniel Tse in the blog of Google where they announced initial results of a research noted.
File:Aquote2.png

According to the American society on fight against cancer, the provided technology can incredibly be important for medicine as the breast cancer throughout life develops at every eighth woman.[1]

Notes